title: Is it time to reconsider combination lipid therapy in high-risk diabetic patients?
authors.affiliation: aInternal Medicine bAdult Congenital Heart Center, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Alexander J
authors.initials: AJ
authors.lastname: Blood
authors.forename: Richard A
authors.initials: RA
authors.lastname: Krasuski
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000378:metabolism; D048909:Diabetes Complications / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D050356:Lipid Metabolism / Q000187:drug effects*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors